Midodrine
Other
| IV Dose | No IV form |
| Oral dose | Adults: 10 mg TID recommended, 3rd dose not later than 6 pm. |
| Levels | unknown |
| Kinetics | Direct effect of metabolite on alpha receptors. Peak levels of metabolite at 1-2 hours, half-life of 3-4 hours. |
| Cautions | Supine and/or sitting hypertension should be checked for after initiation of therapy. Symptoms may include heart pounding, headache, blurred vision. |
| Interactions | May potentiate vagal bradycardia with digoxin. Avoid other vasoconstrictors (e.g. phenylephrine, phenylpropanolamine, dihydroergotamine) Effects antagonized by prazosin) |
| Preparations | ProAmatine scored tablets, 2.5, 5 mg |
| FDA approval in children | no |